Neutral evolution in paroxysmal nocturnal hemoglobinuria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 47, 2008, Pages 18496-18500

  Dingli, David ^a   Luzzatto, Lucio ^b,c   Pacheco, Jorge M ^d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c ISTITUTO TOSCANO TUMORI   (Italy)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

Hematopoiesis; Mathematical modeling; Mutation; Stem cells; Stochastic dynamics

Indexed keywords

ADULT; ARTICLE; BONE MARROW; CLINICAL ARTICLE; HUMAN; INCIDENCE; MATHEMATICAL MODEL; MOLECULAR EVOLUTION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; SIMULATION; STATISTICS; STEM CELL;

ADULT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MEMBRANE PROTEINS; MODELS, THEORETICAL; MUTATION; STOCHASTIC PROCESSES;

EID: 57449083619     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0802749105     Document Type: Article

References (56)

1. Parker C, et al. (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106:3699-3709.
2. Luzzatto L, Bessler M, Rotoli B (1997) Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? Cell 88:1-4.
3. Hillmen P, Bessler M, Mason PJ, Watkins WM, Luzzatto L (1993) Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 90:5272-5276.
4. Miyata T, et al. (1994) Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 330:249-255.
5. Rotoli B, Luzzatto L (1989) Paroxysmal nocturnal hemoglobinuria. Semin Hematol 26:201-207.
6. Karadimitris A, Luzzatto L (2001) The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria. Leukemia 15:1148-1152.
7. Inoue N, et al. (2006) Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 108:4232-4236.
8. Gordon MY, Blackett NM (1994) Routes to repopulation - a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia 8:1068-1073.
9. Dingli D, Pacheco JM (2006) Allometric scaling of the active hematopoietic stem cell pool across mammals. PLoS ONE 1:e2.
10. Dingli D, Pacheco JM (2007) Ontogenic growth of the haemopoietic stem cell pool in humans. Proc Biol Sci 274:2497-2501.
11. Dingli D, Traulsen A, Pacheco JM (2007) Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 6:461-466.
12. Rufer N, et al. (1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190:157-167.
13. Vaziri H, et al. (1994) Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860.
14. Shepherd BE, Guttorp P, Lansdorp PM, Abkowitz JL (2004) Estimating human hematopoietic stem cell kinetics using granulocyte telomere lengths. Exp Hematol 32:1040-1050.
15. Gale RE, Fielding AK, Harrison CN, Linch DC (1997) Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br J Haematol 98:512-519.
16. McKenzie JL, Gan OI, Doedens M, Wang JC, Dick JE (2006) Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat Immunol 7:1225-1233.
17. Abkowitz JL, et al. (1990) Evidence for the maintenance of hematopoiesis in a large animal by the sequential activation of stem-cell clones. Proc Natl Acad Sci USA 87:9062-9066.
18. Buescher ES, Alling DW, Gallin JI (1985) Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest 76:1581-1584.
19. Brody S (1964) in Bioenergetics and Growth (Hafner Press, Darien, CT).
20. Ewens WJ (2004) in Mathematical Population Genetics (Springer, NY).
21. Araten DJ, Luzzatto L (2006) The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 108:734-736.
22. Nash R, Storb R, Neiman P (1988) Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood 72:2031-2037.
23. Araten DJ, et al. (2005) A quantitative measurement of the human somatic mutation rate. Cancer Res 65:8111-8117.
24. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 96:5209-5214.
25. Abkowitz JL, Catlin SN, McCallie MT, Guttorp P (2002) Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 100:2665-2667.
26. Michor F, et al. (2005) Dynamics of chronic myeloid leukaemia. Nature 435:1267-1270.
27. Dingli D, Traulsen A, Pacheco JM (2007) Compartmental architecture and dynamics of hematopoiesis. PLoS ONE 2:e345.
28. Hu R, et al. (2005) PIG-A mutations in normal hematopoiesis. Blood 105:3848-3854.
29. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253-1258.
30. Nishimura J, et al. (2004) Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 83:193-207.
31. Bessler M, Mason PJ, Hillmen P, Luzzatto L (1994) Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 87:863-866.
32. Bessler M, Mason P, Hillmen P, Luzzatto L (1994) Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 343:951-953.
33. Mortazavi Y, et al. (2003) The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): A high incidence of multiple mutations and evidence of a mutational hot spot. Blood 101:2833-2841.
34. Traulsen A, Pacheco JM, Dingli D (2007) On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria. Stem Cells 25:3081-3084.
35. Noji H, et al. (2001) The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts. Exp Hematol 29:391-400.
36. Kai T, et al. (2002) Phenotypes and phosphatidylinositol glycan-class A gene abnormalities during cell differentiation and maturation from precursor cells to mature granulocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood 100:3812-3818.
37. Boschetti C, et al. (2004) Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria. Am J Hematol 77:36-44.
38. Rotoli B, Robledo R, Luzzatto L (1982) Decreased number of circulating BFU-Es in paroxysmal nocturnal hemoglobinuria. Blood 60:157-159.
39. Takeda J, et al. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703-711.
40. Keller P, et al. (2001) FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med 194:581-589.
41. Araten DJ, et al. (2002) Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): No evidence for intrinsic growth advantage of PNH clones. Leukemia 16:2243-2248.
42. Brodsky RA, et al. (1999) Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood 93:1749-1756.
43. Horikawa K, et al. (1997) Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood 90:2716-2722.
44. Dingli D, Pacheco JM, Traulsen A (2008) Multiple mutant clones in blood rarely coexist. Phys Rev E Stat Nonlin Soft Matter Phys 77:021915.
45. Kelly RJ, Tooze RM, Doogy GM, Richards SJ, Hillmen P (2007) The investigation of HMGA2 dysregulation and promoter mutations in PIG-M in the molecular pathogenesis of paroxysmal nocturnal haemoglobinuria (PNH). Blood 110:3671.
46. Dacie JV, Lewis SM (1972) Paroxysmal nocturnal haemoglobinuria: Clinical manifestations, haematology, and nature of the disease. Ser Haematol 5:3-23.
47. Young NS (2002) Acquired aplastic anemia. Ann Intern Med 136:534-546.
48. Karadimitris A, et al. (2000) Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 96:2613-2620.
49. Karadimitris A, et al. (2001) Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): Further evidence for a pathogenetic link between T cells, aplastic anaemia, and PNH. Br J Haematol 115:1010-1014.
50. Risitano AM, et al. (2002) Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood 100:178-183.
51. Risitano AM, et al. (2005) Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia 19:217-222.
52. Poggi A, et al. (2005) Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors. Blood 106:2399-2408.
53. Gargiulo L, et al. (2007) Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood 109:5036-5042.
54. Paquette RL, et al. (1997) Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria. Br J Haematol 96:92-97.
55. Abkowitz JL, Catlin SN, Guttorp P (1996) Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med 2:190-197.
56. Peffault de Latour R, et al. (2008) Paroxysmal nocturnal hemoglobinuria: Natural history of disease subcategories. Blood 112:3099-3106.